About MEDBOT-B Company

We are a first-tier surgical robotics company committed to addressing the cutting-edge development needs of minimally traumatic surgery, using cutting-edge research and industry integration in the fields of robotics, intelligent control, sensing and information to innovatively provide comprehensive solutions for robotic intelligent surgery that can prolong and reshape lives. After years of R&D, innovation and industrial accumulation, the group has developed into a group operating company that comprehensively masters the underlying technology of the entire chain of surgical robots. It has integrated and platform-based expansion capabilities in various disciplines such as light, mechanical, electrical, control, software, computing, and imaging, and has built a comprehensive surgical robot technology innovation platform and a sound industrialized operation system, covering all aspects of R&D, clinical trials, registration and supply chain management, and marketing. The Group is currently the only surgical robot company in the world whose business covers the five “golden tracks” of endoscopy, orthopedics, panvascularization, natural cavities, and percutaneous puncture. It has accumulated several products in various stages of research and development, clinical, registration and commercialization. The company's three flagship products, Tumai, Dragonfly Eye and Honghu, have all been approved for listing through the green channel.